BidaskClub cut shares of Express Scripts (NASDAQ:ESRX) from a buy rating to a hold rating in a research note released on Wednesday, March 14th.
Other equities analysts have also recently issued reports about the stock. SunTrust Banks reaffirmed a buy rating and set a $95.00 price target on shares of Express Scripts in a research note on Friday, January 12th. Zacks Investment Research cut shares of Express Scripts from a strong-buy rating to a hold rating in a research note on Tuesday, March 13th. Robert W. Baird raised shares of Express Scripts from a neutral rating to an outperform rating and boosted their price objective for the company from $72.00 to $81.00 in a research report on Friday, December 15th. William Blair cut shares of Express Scripts from an outperform rating to a market perform rating in a research report on Thursday, March 8th. Finally, Raymond James Financial reissued a sell rating on shares of Express Scripts in a research report on Friday, December 15th. Three research analysts have rated the stock with a sell rating, fourteen have given a hold rating and five have given a buy rating to the stock. Express Scripts has an average rating of Hold and an average price target of $81.97.
Shares of ESRX stock traded down $1.30 on Wednesday, hitting $67.88. 3,171,515 shares of the stock traded hands, compared to its average volume of 5,700,227. The company has a market capitalization of $38,846.72, a price-to-earnings ratio of 9.56, a PEG ratio of 0.85 and a beta of 0.99. Express Scripts has a 52 week low of $55.80 and a 52 week high of $85.07. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.67 and a quick ratio of 0.55.
Express Scripts (NASDAQ:ESRX) last announced its quarterly earnings results on Tuesday, February 27th. The company reported $2.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.09 by $0.07. The company had revenue of $25.38 billion for the quarter, compared to the consensus estimate of $25.07 billion. Express Scripts had a net margin of 4.51% and a return on equity of 25.19%. Express Scripts’s revenue for the quarter was up 2.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.88 EPS. equities research analysts expect that Express Scripts will post 9.35 earnings per share for the current fiscal year.
Express Scripts announced that its board has authorized a stock repurchase program on Monday, December 18th that authorizes the company to buyback 45,000,000 outstanding shares. This buyback authorization authorizes the company to buy shares of its stock through open market purchases. Shares buyback programs are often an indication that the company’s management believes its shares are undervalued.
In other Express Scripts news, insider Christine Houston sold 19,889 shares of the business’s stock in a transaction that occurred on Thursday, March 15th. The shares were sold at an average price of $76.69, for a total transaction of $1,525,287.41. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, VP Everett Neville sold 4,895 shares of the business’s stock in a transaction that occurred on Thursday, March 1st. The stock was sold at an average price of $75.26, for a total transaction of $368,397.70. The disclosure for this sale can be found here. In the last three months, insiders have sold 28,233 shares of company stock worth $2,173,054. 0.68% of the stock is owned by insiders.
Several hedge funds have recently added to or reduced their stakes in ESRX. SeaCrest Wealth Management LLC purchased a new stake in shares of Express Scripts in the 4th quarter valued at $105,000. Bank of Nova Scotia Trust Co. purchased a new stake in Express Scripts during the third quarter worth $120,000. Aevitas Wealth Management Inc. purchased a new stake in Express Scripts during the fourth quarter worth $128,000. Financial Gravity Companies Inc. purchased a new stake in Express Scripts during the fourth quarter worth $142,000. Finally, Monroe Bank & Trust MI boosted its holdings in Express Scripts by 74.8% during the third quarter. Monroe Bank & Trust MI now owns 2,266 shares of the company’s stock worth $156,000 after buying an additional 970 shares in the last quarter. 89.44% of the stock is currently owned by institutional investors and hedge funds.
TRADEMARK VIOLATION WARNING: This piece was first posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this piece on another publication, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark legislation. The original version of this piece can be viewed at https://www.dispatchtribunal.com/2018/04/07/express-scripts-esrx-rating-lowered-to-hold-at-bidaskclub.html.
Express Scripts Company Profile
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.